Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

BGM0504

A Study of BGM0504 Injection in Participants With Obesity or Overweight

BrightGene Bio-Medical Technology Co · Phase 3 · Completed · Enrollment 652

NCT06704581

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
5 mg BGM0504 injectionn/rn/rn/rn/r
10 mg BGM0504 injectionn/rn/rn/rn/r
15 mg BGM0504 injectionn/rn/rn/rn/r
BGM0504 placebon/rn/rn/rn/r

Not shown

  • 5 mg BGM0504 injection: endpoint not reported
  • 10 mg BGM0504 injection: endpoint not reported
  • 15 mg BGM0504 injection: endpoint not reported
  • BGM0504 placebo: endpoint not reported